Efficacy of Dextenza Insert in Upper vs Lower Punctum Following Cataract Surgery With PCIOL.

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Cataract
Interventions
DRUG

Dextenza 0.4Mg Ophthalmic Insert

(dexamethasone ophthalmic insert)-for the treatment of ocular inflammation and pain following following ophthalmic surgery.

Trial Locations (1)

45405

Iworks Laser & Vision Center, Dayton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ocular Therapeutix, Inc.

INDUSTRY

lead

Iworks Laser and Vision Center

OTHER